Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib

SUZHOU, China, and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a US study ...

2023-12-11 13:30 1111

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest efficacy and safety...

2023-12-11 13:14 1108

MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group

SAO PAULO, Dec. 10, 2023 /PRNewswire/ -- MGI Tech Co. Ltd., a company committed to building core tools and technology to lead life science, today announced partnerships with Genos Médica, aMexico-based specialized center in genomics, and TCL Group, a company dedicated to the import and sales of l...

2023-12-11 11:26 1138

MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group

Global Times: TV drama 'Welcome to Milele' represents decades-old China-Africa medical aid cooperation

BEIJING, Dec. 11, 2023 /PRNewswire/ -- This year marks the 60th anniversary sinceChina sent its first medical team to aid Algeria on April 6, 1963. Over the past six decades, China has dispatched over 30,000 medical professionals to 76 countries and regions across the world. Currently, Chinese m...

2023-12-11 09:01 1285

Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery

CAMBRIDGE, Mass., Dec. 10, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and Evive Biotech, a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwid...

2023-12-11 09:00 1052

Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States

* The Phase I PERFORM trial, taking place at four clinical trial centers across the U.S., will evaluate the safety and preliminary efficacy of ATG-031 in patients withadvanced solid tumors or B-cell non-Hodgkin's lymphoma (B-NHL). * ATG-031, discovered and developed in-house by Antengene, is t...

2023-12-11 08:30 1335

Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH

* Full analysis of multinational pivotal study results of golidocitinib in relapsed or refractory peripheral T-cell lymphoma (r/r PTCL) (JACKPOT8 PART B) simultaneously published inThe Lancet Oncology and presented in oral session at the 65th American Society of Hematology Annual Meeting and Ex...

2023-12-10 18:00 1328

Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023

* This new post hoc analysis of the Phase 3 EMERALD trial evaluated elacestrant in the endocrine-sensitive population (CDK4/6 inhibitor duration of at least 12 months) with tumors harboring ESR1 mutations. * This analysis shows a clinically meaningful improvement in progression-free survivala...

2023-12-08 23:13 3289

RewirEd Summit at COP28 makes history by bringing education to the forefront of climate action to impact billions of children and youth globally

DUBAI, UAE, Dec. 8, 2023 /PRNewswire/ -- RewirEd Summit, the first ever global education summit on climate brought together 1,000 participants, including 2 heads of state, 22 ministers, and 28 CEOs, with 260 speakers from diverse sectors, representing 209 entities and 76 countries, to address urg...

2023-12-08 22:06 2156

RewirEd Summit at COP28 makes history by bringing education to the forefront of climate action to impact billions of children and youth globally

WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating

* Ranked in top 1% of the over 100,000 companies evaluated * Recognized for outstanding performance across all areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement * Seen as a trusted partner by global clients for its strong sustainability commitment SHANGHAI, Dec. 8...

2023-12-08 17:40 3521

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

TOKYO, Dec. 8, 2023 /PRNewswire/ -- According to Estimation of the Number of Patients With Mitochondrial Diseases: A Descriptive Study Using in a nationwide database inJapan , 2.9 out of every 100,000 people inJapan ...

2023-12-08 13:40 1631

PharmaBlock Officially Joins United Nations Global Compact

NANJING, China, Dec. 8, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has officially joined the United Nations Global Compact (UNGC), which not only affi...

2023-12-08 12:37 1246

CStone Announces NMPA Approval of Sugemalimab as First-line Treatment for Esophageal Squamous Cell Carcinoma

* Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma. * This marks the 13th NDA approval obtained by CSt...

2023-12-08 12:10 4889

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

HONG KONG, Dec. 8, 2023 /PRNewswire/ -- A randomised, double-blind, placebo-controlled trial (RECOVERY STUDY) conducted by TheChinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and Microbiota I-Center (MagIC) showed that an oral microbiome microencapsulated formula (SIM01)...

2023-12-08 10:38 1763

Full-Life Technologies Breaks Ground for GMP Manufacturing Facility in Belgium to Advance Its End-to-end Solution for Radiopharmaceuticals

GEMBLOUX, Belgium, Dec. 7, 2023 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the construction of its new Good Manufacturing Practices (GMP) compliant manufacturing facility in Gembloux,Belgium, for radiopharmaceuticals. ...

2023-12-08 10:00 1218

Infinitus Co-organizes 2023 Responsibilities for Health Forum: Fostering Quality and Innovation in Traditional Chinese Medicine

GUANGZHOU, China, Dec. 8, 2023 /PRNewswire/ – The 2023 Responsibilities for Health Forum (RHF) was held onDecember 4th, serving as a major event within the 2023 Boao Forum for Chinese Entrepreneurs. The larger forum took place in Boao, Hainan province from December 2nd to December 5th. Hosted by ...

2023-12-08 09:33 1895

Infinitus Co-organizes 2023 Responsibilities for Health Forum: Fostering Quality and Innovation in Traditional Chinese Medicine

Regor Announces Promising Safety And Single Agent Efficacy Data Evaluating RGT-419B In HR+/HER2- Advanced Breast Cancer Patients Who Have Progressed On CDK4/6 Inhibitors And Endocrine Therapy

* RGT-419B, a next generation CDK4 inhibitor, was safe and well tolerated in a First-in-Human Phase 1A single agent dose escalation study. * Monotherapy clinical efficacy was observed in HR+/HER2- advanced breast cancer (ABC) patients who have progressed on CDK4/6 inhibitors (CDK4/6is) and ...

2023-12-08 07:39 1450

AMAZFIT LAUNCHES NEW SPECIAL EDITIONS OF AMAZFIT BALANCE, AND PARTNERS WITH NON-PROFIT ONE TREE PLANTED TO SUPPORT REFORESTATION PROJECTS IN EUROPE

MILPITAS, Calif., Dec. 7, 2023 /PRNewswire/ -- Amazfit , a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), a health technology company, has today unveiled four Special Edition colors of the Amazfit Balance. Along with names inspired by the harmon...

2023-12-08 00:00 1697

2023 SABCS - TransThera announces an oral presentation of tinengotinib clinical data in breast cancer

NANJING, China, Dec. 7, 2023 /PRNewswire/ -- TransThera Sciences (Nanjing) Inc., a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, today announced that an oral presentation of tinengotinib clinical data in breast cancer was delivered at 202...

2023-12-07 21:00 1190

CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum

NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular gene therapy, a series of recent positive developments...

2023-12-07 19:25 1314

1 ... 50 51 525354 55 56 ... 805